Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1, Open-Label, Dose-Escalation and Expansion Study of AGX101, a TM4SF1 Directed Antibody Drug Conjugate in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors
AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at various …
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc.NCT06440005
Phase 2
A Phase 2 Study of Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
The purpose of this research study is to determine if lattice radiation therapy (LRT) will provide better treatment for bulky (large) tumors than current stand…
CancerMetastatic CancerLocally Advanced+2 more
University of CincinnatiNCT06416007